AIDS Vaccines: The Next Frontiers

	Tweet

The AIDS Vaccine Advocacy Coalition on Thursday released its annual report, titled “AIDS Vaccines: The Next Frontiers,” which says that without sufficient future planning, AIDS vaccine research could be slowed.

The report—which lists critical steps to ensure that goals in HIV/AIDS prevention technologies, including AIDS vaccines, are met—summarizes issues and challenges in developing HIV/AIDS prevention technologies.

“Planning for different scenarios for AIDS prevention at this stage is essential,” Mitchell Warren, executive director of AVAC, said, adding, “Without adequate planning and coordination, the issues which will emerge as one or more interventions show signs of some efficacy could slow the pace of future studies.

And we must simultaneously lay the groundwork now to ensure new prevention methods reach the people who need them most.”

The report includes an update on AIDS vaccine science and funding; an analysis of successes and challenges in the search for an AIDS vaccine; a look into how the licensing and distribution of the HPV vaccine can inform future AIDS vaccine initiatives; and an outline of future challenges in AIDS vaccine developments (AVAC release, 9/14). 

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]